Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico

Abstract

Gut microbiota undergoes profound alterations in alcohol cirrhosis. Microbiota-derived products, e.g., short chain fatty acids (SCFA), regulate the homeostasis of the gut-liver axis. The objective was to evaluate the composition and functions of the intestinal microbiota in patients with alcohol-decompensated cirrhosis. Fecal samples of 18 patients and 18 healthy controls (HC) were obtained. Microbial composition was characterized by 16S rRNA amplicon sequencing, SCFA quantification was performed by gas chromatography (GC), and metagenomic predictive profiles were analyzed by PICRUSt2. Gut microbiota in the cirrhosis group revealed a significant increase in the pathogenic/pathobionts genera Escherichia/Shigella and Prevotella, a decrease in beneficial bacteria, such as Blautia, Faecalibacterium, and a decreased α-diversity (p < 0.001) compared to HC. Fecal SCFA concentrations were significantly reduced in the cirrhosis group (p < 0.001). PICRUSt2 analysis indicated a decrease in acetyl-CoA fermentation to butyrate, as well as an increase in pathways related to antibiotics resistance, and aromatic amino acid biosynthesis. These metabolic pathways have been poorly described in the progression of alcohol-related decompensated cirrhosis. The gut microbiota of these patients possesses a pathogenic/inflammatory environment; therefore, future strategies to balance intestinal dysbiosis should be implemented. These findings are described for the first time in the population of western Mexico.

The diversity of the intestinal microbiota in patients with alcohol use disorder and its relationship to alcohol consumption and cognition

“…Previous studies have shown that the abundance of Bacteroidetes and Fusobacteria increased with malignant colorectal cancer ( 22 ). Tonatiuh et al found that the gut microbiota in patients with alcoholic cirrhosis showed a significant increase in the pathogenic/pathogenic genera Escherichia/Shigella and Prevotella , and a decrease in beneficial bacteria such as Blauella , Faecalibacterium and alpha diversity decreased ( 23 ). The correlation of alcohol consumption with the abundance of Fusobacterium OTUs in cancer tissue suggested a possible link between alcohol metabolism and subsequent tumorigenesis caused by Fusobacterium ( 24 ).…”

Diverse gut microbiota pattern between mild and severe cancer‐related fatigue in lung cancer patients treated with first‐line chemotherapy: A pilot study

“…Endotoxins derived from the family Enterobacteriaceae seemed to be a key trigger for systemic inflammation. 25 Specific gut microbiota can drive neuroinflammation and even influence brain function and behavior in rodents and humans. 26 Increased Enterobacteriaceae, a peculiar gut microbiota composition of Parkinsonian patients, has been implicated in disease severity.…”

“…Patients with severe CRF changes in the stool microbial composition were characterized by a lower abundance of gut microbiota capable of SCFA production and have a relative overgrowth of potentially pathogenic taxa. Endotoxins derived from the family Enterobacteriaceae seemed to be a key trigger for systemic inflammation 25 . Specific gut microbiota can drive neuroinflammation and even influence brain function and behavior in rodents and humans 26 .…”

Ameliorative Effect of Mannuronate Oligosaccharides on Hyperuricemic Mice via Promoting Uric Acid Excretion and Modulating Gut Microbiota

“…The content of SCFAs in the colon contents was determined by gas chromatography as previously described and optimized [ 35 ]. The stool sample (about 0.15 g) was weighed, and 1000 μL and 50 μL of 50% sulfuric acid were added and then centrifuged at 5000× g for 10 min.…”